Ignite Creation Date:
2025-12-24 @ 12:04 PM
Ignite Modification Date:
2026-01-28 @ 8:27 AM
Study NCT ID:
NCT02684461
Status:
COMPLETED
Last Update Posted:
2022-06-03
First Post:
2016-02-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization: